Inhibition of upper small intestinal mTOR lowers plasma glucose levels by inhibiting glucose production
The mechanistic target of rapamycin (TOR) functions as an energy sensor and contributes to the control of glucose homeostasis. Here, the authors show that mTOR in the upper small intestine regulates hepatic glucose production and is required for the glucose lowering effect of metformin.
Guardado en:
Autores principales: | T. M. Zaved Waise, Mozhgan Rasti, Frank A. Duca, Song-Yang Zhang, Paige V. Bauer, Christopher J. Rhodes, Tony K. T. Lam |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ed627460bddc4b5ba603759563251b83 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Physiological and therapeutic regulation of glucose homeostasis by upper small intestinal PepT1-mediated protein sensing
por: Helen J. Dranse, et al.
Publicado: (2018) -
The metabolic impact of small intestinal nutrient sensing
por: Frank A. Duca, et al.
Publicado: (2021) -
Tobacco Mosaic Viral Nanoparticle Inhibited Osteoclastogenesis Through Inhibiting mTOR/AKT Signaling
por: Shan Z, et al.
Publicado: (2020) -
PPDPF alleviates hepatic steatosis through inhibition of mTOR signaling
por: Ning Ma, et al.
Publicado: (2021) -
Coordinate autophagy and mTOR pathway inhibition enhances cell death in melanoma.
por: Xiaoqi Xie, et al.
Publicado: (2013)